Iran Plans to Abandon One of Its Homegrown Covid Shots

The defense ministry said there was too little demand for its Fakhravac vaccine to justify producing it, and blamed the health ministry for reneging on promised orders.

Sales of Biogen’s Alzheimer’s Drug Fall Short of Expectations

The drug, Aduhelm, brought in $300,000 in revenue in its first full three months of availability. The company expects the drug to generate minimal revenue for the rest of the year.

Gates Foundation Pledges $120 Million to Help Get Covid Pills Quickly to Poor Countries

Regulatory hurdles and supply chain issues could slow efforts to produce generic versions of Merck’s antiviral molnupiravir for developing nations, despite licensing agreements.

If Cannabis Is Legalized, Should All Drugs Be?

It depends.

Should Pregnant Women Get a Covid-19 Booster Shot?

Experts strongly agree that the shots benefit the mother as well as the fetus.

Should Pregnant People Get a Covid Booster?

Experts strongly agree that the shots benefit the mother as well as the fetus.

Mix-and-Match Covid Boosters: Why They Just Might Work

The F.D.A. may authorize booster shots of vaccines different from the ones that Americans originally received. The science behind the move is promising.

F.D.A. to Allow ‘Mix and Match’ Approach for Covid Booster Shots

The agency may act this week, when it is expected to authorize booster shots for recipients of the Moderna and Johnson & Johnson vaccines.

Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines?

Merck has taken a step to make its antiviral pill available in poor nations, but many obstacles remain for broad access to coronavirus drugs.

Elizabeth Holmes Trial: Key Moments From Week 6

Testimony addressed the question of whether Theranos was misleading and deceiving big corporations to get money.